| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |